Unicycive Resubmits NDA for Oxylanthanum Carbonate
Unicycive resubmitted its oxylanthanum carbonate NDA to the FDA with CMC data from a compliant new vendor, anticipating an FDA acceptance within 30 days and a new PDUFA target date six months from now.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed